Genomictree Inc
KOSDAQ:228760
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genomictree Inc
KOSDAQ:228760
|
KR |
|
Wilh Wilhelmsen Holding ASA
F:WML2
|
NO |
|
Sun International Ltd
F:RY1B
|
ZA |
|
A
|
Acom Co Ltd
F:AK5
|
JP |
|
E
|
Equifax Inc
XMUN:EFX
|
US |
|
Sun International Ltd
OTC:SVUFF
|
ZA |
Intrinsic Value
Is Genomictree Inc undervalued or overvalued?
See the intrinsic value estimate for Genomictree Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Genomictree Does
Genomictree is a South Korean molecular diagnostics company focused on cancer detection. It develops and sells DNA methylation-based tests that look for early signs of cancer in patient samples, including blood, urine, or tissue, depending on the product. Its core business is helping hospitals and diagnostic labs identify cancer sooner and with more objective lab testing.
- Headquarters
- Korea KR
- IPO date
- Jul 19, 2016
Revenue & Expenses Breakdown
Genomictree Inc
Earnings Waterfall
Genomictree Inc
The intrinsic value for Genomictree Inc (228760) under the Base Case is hidden KRW.
Compared with the current market price of 9 900 KRW, the stock appears hidden.